Etirinotecan Pegol (NKTR-102) in Third-line Treatment of Patients With Metastatic or Recurrent Non–Small-cell Lung Cancer: Results of a Phase II Study

2018 ◽  
Vol 19 (2) ◽  
pp. 157-162 ◽  
Author(s):  
Charu Aggarwal ◽  
Roger B. Cohen ◽  
Eddy Yu ◽  
Wei-Ting Hwang ◽  
Joshua M. Bauml ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Small Cell ◽  
Line Treatment ◽  
Small Cell Lung ◽  
Etirinotecan Pegol ◽  
Third Line ◽  
Third Line Treatment

scholarly journals Phase II Study of Afatinib as Third‐Line Treatment for Patients in Korea With Stage IIIB/IV Non‐Small Cell Lung Cancer Harboring Wild‐Type EGFR

2014 ◽  
Vol 19 (7) ◽  
pp. 702-703 ◽  
Author(s):  
Myung‐Ju Ahn ◽  
Sang‐We Kim ◽  
Byoung‐Chul Cho ◽  
Jin Seok Ahn ◽  
Dae Ho Lee ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Small Cell ◽  
Line Treatment ◽  
Wild Type ◽  
Small Cell Lung ◽  
Third Line ◽  
Third Line Treatment

scholarly journals Tasisulam Sodium (LY573636 Sodium) as Third-Line Treatment in Patients With Unresectable, Metastatic Non–Small-Cell Lung Cancer: A Phase-II Study

2012 ◽  
Vol 7 (6) ◽  
pp. 1053-1057 ◽  
Author(s):  
Giorgio V. Scagliotti ◽  
Robert Ilaria ◽  
Silvia Novello ◽  
J. von Pawel ◽  
Juergen R. Fischer ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Line Treatment ◽  
Small Cell Lung ◽  
Third Line ◽  
Third Line Treatment

Activity and safety of erlotinib as second- and third-line treatment in elderly patients with advanced non-small cell lung cancer: a phase II trial

2010 ◽  
Vol 5 (4) ◽  
pp. 231-235 ◽  
Author(s):  
David Rossi ◽  
Donatella Dennetta ◽  
Marcello Ugolini ◽  
Vincenzo Catalano ◽  
Paolo Alessandroni ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Elderly Patients ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Line Treatment ◽  
Small Cell Lung ◽  
Third Line ◽  
Third Line Treatment

Second and third line treatment in non-small cell lung cancer

2009 ◽  
Vol 71 (2) ◽  
pp. 117-126 ◽  
Author(s):  
Adolfo Favaretto ◽  
Giulia Pasello ◽  
Cristina Magro ◽  
Clorinda Schettino ◽  
Cesare Gridelli
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Line Treatment ◽  
Small Cell Lung ◽  
Third Line ◽  
Third Line Treatment
Sign in / Sign up

Export Citation Format

Share Document